BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12851681)

  • 21. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
    Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
    Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
    He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
    Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
    Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.
    Asou H; Verbeek W; Williamson E; Elstner E; Kubota T; Kamada N; Koeffler HP
    Int J Oncol; 1999 Nov; 15(5):1027-31. PubMed ID: 10536188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
    Sharma C; Pradeep A; Pestell RG; Rana B
    J Biol Chem; 2004 Apr; 279(17):16927-38. PubMed ID: 14764597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of aromatase by nuclear receptors.
    Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
    Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
    Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium.
    Tsibris JC; Porter KB; Jazayeri A; Tzimas G; Nau H; Huang H; Kuparadze K; Porter GW; O'Brien WF; Spellacy WN
    Cancer Res; 1999 Nov; 59(22):5737-44. PubMed ID: 10582693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
    J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
    Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
    Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene.
    Frohnert BI; Hui TY; Bernlohr DA
    J Biol Chem; 1999 Feb; 274(7):3970-7. PubMed ID: 9933587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
    Satoh T; Toyoda M; Hoshino H; Monden T; Yamada M; Shimizu H; Miyamoto K; Mori M
    Oncogene; 2002 Mar; 21(14):2171-80. PubMed ID: 11948400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
    Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
    J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinational effect of PPARĪ³ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
    Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
    Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway.
    Singh RR; Gururaj AE; Vadlamudi RK; Kumar R
    J Biol Chem; 2006 Jun; 281(22):15394-404. PubMed ID: 16574651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.